China Resources Obtaining the pace of the integration of controlling assets of Beidao Group to accelerates
Release time: 2011-06-29 & nbsp & nbsp & nbsp Source:
Business Club, June 28 News Shuanghe Pharmaceutical、Wandong Medical Announcement on the 28th，Approved by the State -owned Assets Supervision and Administration Commission of the State Council，Beijing State -owned Capital Management Center will transfer 1%of the State -owned equity of Bei Pharmaceutical Group to China Corporation Corporation。China China Resources as a result of the controlling stake from Bei Pharmaceutical Group，The integration of its assets of its pharmaceutical assets and Northern Pharmaceutical Group is expected to accelerate into the substantive operation stage。
China Resources My stake betting appfinally stake betting appreceived the control of the North Medicine
Before transfer of equity，China China Resources and Beijing National Management Center hold 50%equity of Bei Pharmaceutical Group，Common control of the North Medicine Group。After the transfer is completed，China China Resources Corporation will directly hold 1%equity of Beidao Pharmaceutical Group，A 50%equity of Beidao Pharmaceutical Group through the wholly -owned subsidiary of China Resources North Pharmaceutical，Total 51%equity of Bei Pharmaceutical Group。As a result, the actual controller of the North Pharmaceutical Group is changed to China Resources。
At the same time，Bei Pharmaceutical Group holds Shuanghe Pharmaceutical 280,820,611 shares of equity，accounting for 49.12%of the shares of Shuanghe Pharmaceuticals; holding Wandong Medical 111,501,Equity of 000 shares，51.51%of all the issued shares of Wandong Medical。This equity transfer also caused the actual controller of Shuanghe Pharmaceutical and Wandong Medical.，China Resources becomes the actual controller of Shuanghe Pharmaceutical and Wandong Medical。
Announcement，China Resources has not continued to increase holdings of Shuanghe Pharmaceuticals in the next 12 months、Plan for Wandong Medical Shares，Nor sold or transferred the double crane pharmaceutical industry due to the rights owned by this acquisition、Plan for Wandong Medical Shares。
According to the "Anti -Monopoly Law"、"Administrative Measures for the acquisition of listed companies" and stake sports betting appstake sports betting appother relevant regulations，China China Resources Corporation will perform relevant operators for centralized review and offer acquisition for exemption obligations。
The pace of asset integration accelerates
April 2010，China Resources Group, a wholly -owned subsidiary of China Resources Co., Ltd., and the Beijing Municipal Government formally signed the "Strategic Cooperation Framework Agreement on the Development of the Medical Industry and Microelectronics Industry"。China Resources is a wholly -owned subsidiary of China Resources。
According to the agreement，The two parties will integrate the medical resources of China and China Resources，Actively promote the strategic reorganization of China Resources Group's medical resources and North Pharmaceutical Group，Improve industry status，Jointly build a leading company in the domestic biomedical industry in Beijing。China CR and Beijing State -owned Assets Supervision Commission intends to reorganize the rights and interests of China Resources Group and Bei Pharmaceutical Group。
Some analysts say，"The signing of the framework agreement means that China Resources Group has made significant progress in the integration process of the domestic pharmaceutical industry。"and judge，China Resources further increases the equity ratio of Bei Pharmaceutical Group，Get Holding status，Prepare for strategic reorganization and overall listing。
China Resources Group's current My stake betting appmedical assets mainly stake sports betting appinclude China Resources Three Nine、East Ejiao、Huayuan Medicine、Shanghai Medical Device Group。And Beidong Medical Group owns Wandong Medical、Shuanghe Pharmaceutical、Zizhu Pharmaceutical and Beijing Pharmaceutical Company。Integrated the assets of Beidao Group，It will help China Resources Medicine to improve the industrial chain，Enhance competitiveness。
Gudu Securities Analysts think，The integration steps of China Resources Group are roughly divided into three steps: the first step，Dipping off its non -pharmaceutical industry，Focus on the main medical business; step 2，After obtaining the control of the North Medicine Group，Implement the optimization and integration of China Resources Group's pharmaceutical assets; step 3，Realize the overall listing。
Companies involving China Resources Integrated Beidong Medical are mainly Wandong Medical、Shuanghe Pharmaceutical、China Resources Three Nine、East Ejiao。
Analysts think，Wandong Medical will undoubtedly become the integrated platform for China Resources Medical Device Business Integration。And Shuanghe Pharmaceutical will be expected to become a platform for China Resources Pharmaceutical Pharmaceutical and Large Lights Integration。Stake Sports BettingChina Resources Sanjiu is positioned as a platform for China Resources Traditional Chinese Medicine Business Integration，Therefore，If you have obtained the stake sports betting appcontrolling stake of the Bei Pharmaceutical Group，China Resources Sanjiu may integrate Chinese medicine assets under the North Medicine Group in the future。East Ejiao Lack of relevant assets that can be integrated，but，Northern Pharmaceutical Group's many commercial retail channels，It will help expand the company's sales channel。(Li Shaolin)
China Resources My stake betting appfinally stake betting appreceived the control of the North Medicine
Before transfer of equity，China China Resources and Beijing National Management Center hold 50%equity of Bei Pharmaceutical Group，Common control of the North Medicine Group。After the transfer is completed，China China Resources Corporation will directly hold 1%equity of Beidao Pharmaceutical Group，A 50%equity of Beidao Pharmaceutical Group through the wholly -owned subsidiary of China Resources North Pharmaceutical，Total 51%equity of Bei Pharmaceutical Group。As a result, the actual controller of the North Pharmaceutical Group is changed to China Resources。
At the same time，Bei Pharmaceutical Group holds Shuanghe Pharmaceutical 280,820,611 shares of equity，accounting for 49.12%of the shares of Shuanghe Pharmaceuticals; holding Wandong Medical 111,501,Equity of 000 shares，51.51%of all the issued shares of Wandong Medical。This equity transfer also caused the actual controller of Shuanghe Pharmaceutical and Wandong Medical.，China Resources becomes the actual controller of Shuanghe Pharmaceutical and Wandong Medical。
Announcement，China Resources has not continued to increase holdings of Shuanghe Pharmaceuticals in the next 12 months、Plan for Wandong Medical Shares，Nor sold or transferred the double crane pharmaceutical industry due to the rights owned by this acquisition、Plan for Wandong Medical Shares。
According to the "Anti -Monopoly Law"、"Administrative Measures for the acquisition of listed companies" and stake sports betting appstake sports betting appother relevant regulations，China China Resources Corporation will perform relevant operators for centralized review and offer acquisition for exemption obligations。
The pace of asset integration accelerates
April 2010，China Resources Group, a wholly -owned subsidiary of China Resources Co., Ltd., and the Beijing Municipal Government formally signed the "Strategic Cooperation Framework Agreement on the Development of the Medical Industry and Microelectronics Industry"。China Resources is a wholly -owned subsidiary of China Resources。
According to the agreement，The two parties will integrate the medical resources of China and China Resources，Actively promote the strategic reorganization of China Resources Group's medical resources and North Pharmaceutical Group，Improve industry status，Jointly build a leading company in the domestic biomedical industry in Beijing。China CR and Beijing State -owned Assets Supervision Commission intends to reorganize the rights and interests of China Resources Group and Bei Pharmaceutical Group。
Some analysts say，"The signing of the framework agreement means that China Resources Group has made significant progress in the integration process of the domestic pharmaceutical industry。"and judge，China Resources further increases the equity ratio of Bei Pharmaceutical Group，Get Holding status，Prepare for strategic reorganization and overall listing。
China Resources Group's current My stake betting appmedical assets mainly stake sports betting appinclude China Resources Three Nine、East Ejiao、Huayuan Medicine、Shanghai Medical Device Group。And Beidong Medical Group owns Wandong Medical、Shuanghe Pharmaceutical、Zizhu Pharmaceutical and Beijing Pharmaceutical Company。Integrated the assets of Beidao Group，It will help China Resources Medicine to improve the industrial chain，Enhance competitiveness。
Gudu Securities Analysts think，The integration steps of China Resources Group are roughly divided into three steps: the first step，Dipping off its non -pharmaceutical industry，Focus on the main medical business; step 2，After obtaining the control of the North Medicine Group，Implement the optimization and integration of China Resources Group's pharmaceutical assets; step 3，Realize the overall listing。
Companies involving China Resources Integrated Beidong Medical are mainly Wandong Medical、Shuanghe Pharmaceutical、China Resources Three Nine、East Ejiao。
Analysts think，Wandong Medical will undoubtedly become the integrated platform for China Resources Medical Device Business Integration。And Shuanghe Pharmaceutical will be expected to become a platform for China Resources Pharmaceutical Pharmaceutical and Large Lights Integration。Stake Sports BettingChina Resources Sanjiu is positioned as a platform for China Resources Traditional Chinese Medicine Business Integration，Therefore，If you have obtained the stake sports betting appcontrolling stake of the Bei Pharmaceutical Group，China Resources Sanjiu may integrate Chinese medicine assets under the North Medicine Group in the future。East Ejiao Lack of relevant assets that can be integrated，but，Northern Pharmaceutical Group's many commercial retail channels，It will help expand the company's sales channel。(Li Shaolin)
